InvestorsHub Logo
Followers 17
Posts 752
Boards Moderated 0
Alias Born 10/20/2013

Re: xoc post# 138728

Saturday, 01/30/2016 10:39:31 AM

Saturday, January 30, 2016 10:39:31 AM

Post# of 403772
Agree. And by re-enrolling and continuing the ph1 they save time while exploring the wider possible use of K instead of having to do new ph 1/2 or 2. Again, this could also lead to an application for breakthrough designation of the data is strong enough. DF would never do this and spend money on an extended ph1 where safety has been proven a long time ago if they did not see possible efficacy in the horizon.